Results 41 to 50 of about 12,173,418 (313)

Digital Cognitive Phenotyping for Differential Diagnosis and Monitoring in Neurological Conditions

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To assess the utility, accessibility, and equivalence to supervised scales of online cognitive assessment in older individuals with cognitive impairment. Methods Patients with Alzheimer's disease (AD, n = 31), idiopathic normal pressure hydrocephalus (iNPH, n = 26), and traumatic brain injury (TBI, n = 23) completed online cognitive ...
Martina Del Giovane, Valentina Giunchiglia, Michael C. B. David, Magdalena A. Kolanko, William R. Trender, Peter J. Hellyer, Harmeena Kaur, David J. Sharp, Christopher Carswell, Paresh A. Malhotra, Adam Hampshire   +10 more
wiley   +1 more source

EL PLACEBO: LUCES Y SOMBRAS Placebo: Lights and shadows

Revista Habanera de Ciencias Médicas, 2008
Se realiza una revisión sobre el placebo definiéndose su concepto, así como del efecto placebo, sus reacciones en el organismo, utilidad en las investigaciones, sus posibles usos en la práctica médica y los peligros de su empleo.
José Díaz Novás
doaj  

The Role of Expectation and Beliefs on the Effects of Non-Invasive Brain Stimulation

Brain Sciences, 2021
Non-invasive brain stimulation (NIBS) techniques are used in clinical and cognitive neuroscience to induce a mild magnetic or electric field in the brain to modulate behavior and cortical activation.
Miriam Braga, Diletta Barbiani, Mehran Emadi Andani, Bernardo Villa-Sánchez, Michele Tinazzi, Mirta Fiorio   +5 more
doaj   +1 more source

Placebo effect characteristics observed in a single, international, longitudinal study in Huntington's disease. [PDF]

, 2011
Item does not contain fulltextBACKGROUND: Classically, clinical trials are based on the placebo-control design. Our aim was to analyze the placebo effect in Huntington's disease.
Camu, W, Albanese, A, Walli, J, Meierkord, H, Gómez, Jc, Bachoud Lévi, Ac, Kwiecinski, H, Seppi, K, de Yébenes, J. G., Khoris, J, Trejo, J. M., Pages, M, Messouak, O, de Jong, D, Arguillère, S, Kowalczys, H, José María Trejo Gabriel y Galán, Ecker, D, Vingerhoets, F, Poewe, W, Cervera, C, Kuznik, D, del Puerto, I., Zarranz, Jj, Niezgoda, A, Muñoz, Je, Gawel, M, null null, Rascol, O, Przuntek, H, Zangerl, A, Andrich, J, Castillio, V, Schober, T, López, E, Kramer, B, Justo Garcia de Yébenes, Warrenburg, B.P.C. van de, Dürr, A, Sesar, A, Arconada, O. F., Autret, A, Dubois, B, Broussolle, E, Ludolph, Ac, Lukasik, M, Ochudło, S, Grimbergen, Y, Gabriel y Galàn, J. .M, Cubo, E., Inés del Puerto, Azulay, Jp, Auff, E, Viallet, F, Hannequin, D, Goizet, C, Priller, J, Alegre, J, Durif, F, Miguel González, Wider, C., Łukasik, M, Janik, P, Olga Fernández Arconada, Redondo, L, van Vugt, J, Saudeau, D, Kälin, A, Krystkowiak, P, Thibaut Tanchou, S, Foeldy, D, Jaumà, S, Bakchine, S, Landwehrmeyer, Gb, Ott, E, Tolosa, E, Gonzáles, M., Tison, F, Fanjul, S, Mateo, D, Cantarero, S, Chacón, J, Bloch, F, Kremer, H, Galitzky, M, Gámez, J, Rojo, A, Resch, F, Destée, A, Solis, P, Wenzel, K, Modestowicz, R, Esther Cubo, Świat, M, Burguera, Ja, Abbruzzese, G, Tallaksen, C, Demonet, Jf, Kremer, H.P.H., de Yébenes, Jg, FILLA, ALESSANDRO, et al., Lallement, F, Ríos, C, Burgunder, Jm, Puerto, I. del, Roos, R, Squitieri, F, Bas, J, Gamero, Ma, Guillamo, Js, Mollion, H, Pilczuk, B, Wenning, G, Engles, A, García Ruiz, P, De, J. G., Hernández, J, Gabriel y Galan, J.M., Puerto, I. d., Gonzalez, M., Lezcano, E, Dinca, L, Castro, A, Madigand, M, Dose, M, Yebenes, J.G. de, van de Warrenburg, B, Roldán, Sg, Descals, Am, Fontán, A, Saft, C, European Huntington's Disease Initiative Study Group,, Nirkko, Arto Christian, Leblhuber, F, Arconada, O.F., Memin, A, Pasquier, F, Calopa, M, Kraus, Ph, López del Val, J, Nirkko, A, de Yébenes, J.G.   +142 more
core   +1 more source

Effects of Add‐On Icosapent Ethyl With Standard Treatment on Functional Outcomes and Inflammatory Biomarkers in Acute Ischemic Stroke: A Blinded Randomized Controlled Trial

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Ischemic stroke, a major cause of mortality and long‐term disability, results from the abrupt cessation of cerebral blood flow due to vascular occlusion or rupture. Icosapent Ethyl (EPA‐EE), approved for hypertriglyceridemia, has anti‐inflammatory and antithrombotic properties that may lessen ischemic damage.
Mitra Mahmoudi Meymand, Seyed Hossein Aghamiri, Saeed Mohmammad Soleymani, Shadiyeh Bararpoor Poshkohi, Samaneh Masoudi, Hadi Esmaily   +5 more
wiley   +1 more source

The transferable placebo effect from pain to emotion: Changes in behavior and EEG activity [PDF]

, 2009
Past studies indicate that the placebo expectation established by analgesic treatment significantly relieves pain perception, while ataractic treatment significantly alleviates unpleasant arousal evoked by negative picture processing.
J. Luo, Zhang, Wencai, Luo, Jing
core  

Historical Aspects of Placebo Analgesia

, 2013
The placebo effect has been a topic of interest in medicine for many hundreds of years. A historical evaluation of the topic demonstrates how the origin of the word, and its initial use in society and in medicine, has shaped its meaning over many years ...
Damien Finniss, Finniss, Damien
core   +1 more source

Informed consent and placebo effects: a content analysis of information leaflets to identify what clinical trial participants are told about placebos [PDF]

, 2012
BackgroundPlacebo groups are used in randomised clinical trials (RCTs) to control for placebo effects, which can be large. Participants in trials can misunderstand written information particularly regarding technical aspects of trial design such as ...
Alison E. M. Adams (317941), George T. Lewith (317942), Kaptchuk, Ted J., Ted J Kaptchuk, Ted J. Kaptchuk (234474), Bishop Felicity L., Lewith George T., Adams, Alison E. M., Kaptchuk, Ted, Bishop, Felicity L., Felicity L. Bishop (317940), Adams Alison E. M., Alison E M Adams, Kaptchuk Ted J., Lewith, George, Lewith, George T., Felicity L Bishop, Adams, Alison E.M., George T Lewith   +18 more
core   +1 more source

Intracerebral Hemorrhage Induces Monocyte TNF Signaling in Patients That Is Suppressed by BAF312

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Intracerebral hemorrhage (ICH) causes high morbidity and mortality, with neurotoxic inflammation driven by infiltrating monocytes. This study is an in‐depth longitudinal examination of the immune response during the first week of ICH in the presence and absence of the immunomodulatory drug BAF312 (Siponimod).
Jonathan Howard DeLong, Sebastian Díaz‐Pérez, Kevin Navin Sheth, Jang‐Ho Cha, C. J. Malanga, Patricia G. M. Wagner, Nicole Pezous, Aurelie Hanin, Kyle B. Walsh, H. E. Hinson, Lauren Hachmann Sansing   +10 more
wiley   +1 more source

Inebilizumab in AQP4‐Seropositive NMOSD: One‐Year Follow‐Up From a Multicenter, Real‐World Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Real‐world evidence on inebilizumab among neuromyelitis optica spectrum disorder (NMOSD) patients is lacking. This study assessed inebilizumab among Chinese patients with aquaporin 4 autoantibody (AQP4‐IgG)‐seropositive NMOSD in a real‐world setting.
Mengcui Gui, Jiayang Zhan, Wei Li, Tao Jin, Dan He, Daishi Tian, Zhijun Li, Jing Lin, Yue Li, Hongyu Zhou, Bitao Bu   +10 more
wiley   +1 more source